India · Delayed Price · Currency is INR Max Healthcare Institute Statistics
Total Valuation
NSE:MAXHEALTH has a market cap or net worth of INR 974.15 billion. The enterprise value is 1.00 trillion.
| Market Cap | 974.15B |
| Enterprise Value | 1.00T |
Important Dates
The next estimated earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | Jul 3, 2026 |
Share Statistics
| Current Share Class | 973.27M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.05% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 23.73% |
| Owned by Institutions (%) | 49.11% |
| Float | 699.07M |
Valuation Ratios
The trailing PE ratio is 66.86 and the forward PE ratio is 50.18.
| PE Ratio | 66.86 |
| Forward PE | 50.18 |
| PS Ratio | 11.18 |
| PB Ratio | 9.06 |
| P/TBV Ratio | 20.55 |
| P/FCF Ratio | 654.71 |
| P/OCF Ratio | 59.64 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 43.50, with an EV/FCF ratio of 673.62.
| EV / Earnings | 68.79 |
| EV / Sales | 11.50 |
| EV / EBITDA | 43.50 |
| EV / EBIT | 54.27 |
| EV / FCF | 673.62 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 1.51 |
| Debt / FCF | 23.38 |
| Interest Coverage | 7.99 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 11.60% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 4.90% |
| Revenue Per Employee | 5.76M |
| Profits Per Employee | 963,961 |
| Employee Count | 15,114 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:MAXHEALTH has paid 2.54 billion in taxes.
| Income Tax | 2.54B |
| Effective Tax Rate | 14.84% |
Stock Price Statistics
The stock price has decreased by -12.85% in the last 52 weeks. The beta is 0.11, so NSE:MAXHEALTH's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | -12.85% |
| 50-Day Moving Average | 1,039.40 |
| 200-Day Moving Average | 1,034.67 |
| Relative Strength Index (RSI) | 36.74 |
| Average Volume (20 Days) | 1,992,985 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:MAXHEALTH had revenue of INR 87.12 billion and earned 14.57 billion in profits. Earnings per share was 14.91.
| Revenue | 87.12B |
| Gross Profit | 54.47B |
| Operating Income | 18.47B |
| Pretax Income | 17.11B |
| Net Income | 14.57B |
| EBITDA | 22.46B |
| EBIT | 18.47B |
| Earnings Per Share (EPS) | 14.91 |
Balance Sheet
The company has 6.66 billion in cash and 34.78 billion in debt, with a net cash position of -28.13 billion.
| Cash & Cash Equivalents | 6.66B |
| Total Debt | 34.78B |
| Net Cash | -28.13B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 107.47B |
| Book Value Per Share | 110.43 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 16.33 billion and capital expenditures -14.85 billion, giving a free cash flow of 1.49 billion.
| Operating Cash Flow | 16.33B |
| Capital Expenditures | -14.85B |
| Depreciation & Amortization | 3.99B |
| Net Borrowing | 3.98B |
| Free Cash Flow | 1.49B |
| FCF Per Share | n/a |
Margins
Gross margin is 62.52%, with operating and profit margins of 21.20% and 16.72%.
| Gross Margin | 62.52% |
| Operating Margin | 21.20% |
| Pretax Margin | 19.64% |
| Profit Margin | 16.72% |
| EBITDA Margin | 25.78% |
| EBIT Margin | 21.20% |
| FCF Margin | 1.78% |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.20%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 0.20% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.05% |
| Shareholder Yield | 0.25% |
| Earnings Yield | 1.50% |
| FCF Yield | 0.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:MAXHEALTH is 1,170.04, which is 19.51% higher than the current price. The consensus rating is "Buy".
| Price Target | 1,170.04 |
| Price Target Difference | 19.51% |
| Analyst Consensus | Buy |
| Analyst Count | 27 |
| Revenue Growth Forecast (3Y) | 25.63% |
| EPS Growth Forecast (3Y) | 23.44% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |